(MPLX) MPLX - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55336V1008
Stock:
Total Rating 45
Risk 65
Buy Signal -0.38
| Risk 5d forecast | |
|---|---|
| Volatility | 16.4% |
| Relative Tail Risk | -0.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.92 |
| Alpha | 9.95 |
| Character TTM | |
|---|---|
| Beta | 0.521 |
| Beta Downside | 1.017 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.58% |
| CAGR/Max DD | 2.04 |
EPS (Earnings per Share)
Revenue
Description: MPLX MPLX
MPLX LP owns and operates midstream energy infrastructure and logistics assets primarily in the United States. It operates in two segments, Crude Oil and Products Logistics; and Natural Gas and NGL Services. The company is involved in the gathering, processing, and transportation of natural gas; gathering, transportation, fractionation, storage, and marketing of natural gas liquids; gathering, storage, transportation, and distribution of crude oil and refined products, as well as other hydrocarbon-based products and renewables; and sale of residue gas and condensate. It also engages in inland marine businesses, comprising fleet of boats and barges transport light products, heavy oils, crude oil, renewable fuels, chemicals, and feedstocks in the Mid-Continent and Gulf Coast regions, as well as a marine repair facility located on the Ohio River; and distribution of fuel, as well as operates refining logistics, terminals, rail facilities, and storage caverns. In addition, the company operates terminal facilities for the receipt, storage, blending, additization, handling, and redelivery of refined petroleum products through the pipeline, rail, marine, and truck transportation. MPLX GP LLC acts as the general partner of MPLX LP. The company was incorporated in 2012 and is headquartered in Findlay, Ohio. MPLX LP is a subsidiary of Marathon Petroleum Corporation.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 4.91b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 0.70 > 1.0 |
| NWC/Revenue: -11.02% < 20% (prev 0.38%; Δ -11.39% < -1%) |
| CFO/TA 0.14 > 3% & CFO 5.91b > Net Income 4.91b |
| Net Debt (-2.14b) to EBITDA (7.32b): -0.29 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.02b) vs 12m ago -0.20% < -2% |
| Gross Margin: 49.69% > 18% (prev 0.44%; Δ 4925 % > 0.5%) |
| Asset Turnover: 30.78% > 50% (prev 29.07%; Δ 1.71% > 0%) |
| Interest Coverage Ratio: 5.85 > 6 (EBITDA TTM 7.32b / Interest Expense TTM 1.02b) |
Altman Z''
| A: -0.03 (Total Current Assets 2.14b - Total Current Liabilities 3.50b) / Total Assets 43.01b |
| B: error (Retained Earnings missing) |
| C: 0.15 (EBIT TTM 5.97b / Avg Total Assets 40.26b) |
| D: 0.50 (Book Value of Equity 14.30b / Total Liabilities 28.48b) |
Beneish M
| DSRI: none (Receivables none/1.54b, Revenue 12.39b/10.90b) |
| GMI: 0.89 (GM 49.69% / 44.18%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.14 (Revenue 12.39b / 10.90b) |
| TATA: -0.02 (NI 4.91b - CFO 5.91b) / TA 43.01b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of MPLX shares?
As of March 02, 2026, the stock is trading at USD 58.94 with a total of 917,289 shares traded.
Over the past week, the price has changed by +0.24%, over one month by +8.63%, over three months by +9.56% and over the past year by +17.52%.
Over the past week, the price has changed by +0.24%, over one month by +8.63%, over three months by +9.56% and over the past year by +17.52%.
Is MPLX a buy, sell or hold?
MPLX has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold MPLX.
- StrongBuy: 4
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MPLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.7 | -2.1% |
| Analysts Target Price | 57.7 | -2.1% |
MPLX Fundamental Data Overview February 28, 2026
P/E Trailing = 12.1701
P/E Forward = 10.6724
P/S = 5.0487
P/B = 3.6508
P/EG = 2.0245
Revenue TTM = 12.39b USD
EBIT TTM = 5.97b USD
EBITDA TTM = 7.32b USD
Long Term Debt = 24.14b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.50b USD (from shortTermDebt, two quarters ago)
Debt = 26.09b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -2.14b USD (from netDebt column, last quarter)
Enterprise Value = 83.61b USD (59.66b + Debt 26.09b - CCE 2.14b)
Interest Coverage Ratio = 5.85 (Ebit TTM 5.97b / Interest Expense TTM 1.02b)
EV/FCF = 14.15x (Enterprise Value 83.61b / FCF TTM 5.91b)
FCF Yield = 7.07% (FCF TTM 5.91b / Enterprise Value 83.61b)
FCF Margin = 47.69% (FCF TTM 5.91b / Revenue TTM 12.39b)
Net Margin = 39.64% (Net Income TTM 4.91b / Revenue TTM 12.39b)
Gross Margin = 49.69% ((Revenue TTM 12.39b - Cost of Revenue TTM 6.23b) / Revenue TTM)
Gross Margin QoQ = 47.30% (prev 60.82%)
Tobins Q-Ratio = 1.94 (Enterprise Value 83.61b / Total Assets 43.01b)
Interest Expense / Debt = 1.06% (Interest Expense 277.0m / Debt 26.09b)
Taxrate = 0.25% (3.00m / 1.21b)
NOPAT = 5.96b (EBIT 5.97b * (1 - 0.25%))
Current Ratio = 0.61 (Total Current Assets 2.14b / Total Current Liabilities 3.50b)
Debt / Equity = 1.80 (Debt 26.09b / totalStockholderEquity, last quarter 14.53b)
Debt / EBITDA = -0.29 (Net Debt -2.14b / EBITDA 7.32b)
Debt / FCF = -0.36 (Net Debt -2.14b / FCF TTM 5.91b)
Total Stockholder Equity = 14.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.20% (Net Income 4.91b / Total Assets 43.01b)
RoE = 34.79% (Net Income TTM 4.91b / Total Stockholder Equity 14.12b)
RoCE = 15.60% (EBIT 5.97b / Capital Employed (Equity 14.12b + L.T.Debt 24.14b))
RoIC = 16.02% (NOPAT 5.96b / Invested Capital 37.18b)
WACC = 5.77% (E(59.66b)/V(85.75b) * Re(7.83%) + D(26.09b)/V(85.75b) * Rd(1.06%) * (1-Tc(0.00)))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.70%
[DCF] Terminal Value 86.97% ; FCFF base≈5.50b ; Y1≈5.88b ; Y5≈7.10b
[DCF] Fair Price = 209.3 (EV 210.27b - Net Debt -2.14b = Equity 212.41b / Shares 1.01b; r=5.90% [WACC]; 5y FCF grow 7.63% → 2.90% )
EPS Correlation: 56.22 | EPS CAGR: 8.32% | SUE: 0.12 | # QB: 0
Revenue Correlation: 69.54 | Revenue CAGR: 5.87% | SUE: -2.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.08 | Chg7d=-0.021 | Chg30d=-0.026 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.56 | Chg7d=+0.033 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=-0.5%
EPS next Year (2027-12-31): EPS=4.91 | Chg7d=-0.002 | Chg30d=-0.108 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.3% (Discount Rate 7.9% - Earnings Yield 8.2%)
[Growth] Growth Spread = +5.9% (Analyst 5.6% - Implied -0.3%)
P/E Forward = 10.6724
P/S = 5.0487
P/B = 3.6508
P/EG = 2.0245
Revenue TTM = 12.39b USD
EBIT TTM = 5.97b USD
EBITDA TTM = 7.32b USD
Long Term Debt = 24.14b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.50b USD (from shortTermDebt, two quarters ago)
Debt = 26.09b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -2.14b USD (from netDebt column, last quarter)
Enterprise Value = 83.61b USD (59.66b + Debt 26.09b - CCE 2.14b)
Interest Coverage Ratio = 5.85 (Ebit TTM 5.97b / Interest Expense TTM 1.02b)
EV/FCF = 14.15x (Enterprise Value 83.61b / FCF TTM 5.91b)
FCF Yield = 7.07% (FCF TTM 5.91b / Enterprise Value 83.61b)
FCF Margin = 47.69% (FCF TTM 5.91b / Revenue TTM 12.39b)
Net Margin = 39.64% (Net Income TTM 4.91b / Revenue TTM 12.39b)
Gross Margin = 49.69% ((Revenue TTM 12.39b - Cost of Revenue TTM 6.23b) / Revenue TTM)
Gross Margin QoQ = 47.30% (prev 60.82%)
Tobins Q-Ratio = 1.94 (Enterprise Value 83.61b / Total Assets 43.01b)
Interest Expense / Debt = 1.06% (Interest Expense 277.0m / Debt 26.09b)
Taxrate = 0.25% (3.00m / 1.21b)
NOPAT = 5.96b (EBIT 5.97b * (1 - 0.25%))
Current Ratio = 0.61 (Total Current Assets 2.14b / Total Current Liabilities 3.50b)
Debt / Equity = 1.80 (Debt 26.09b / totalStockholderEquity, last quarter 14.53b)
Debt / EBITDA = -0.29 (Net Debt -2.14b / EBITDA 7.32b)
Debt / FCF = -0.36 (Net Debt -2.14b / FCF TTM 5.91b)
Total Stockholder Equity = 14.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.20% (Net Income 4.91b / Total Assets 43.01b)
RoE = 34.79% (Net Income TTM 4.91b / Total Stockholder Equity 14.12b)
RoCE = 15.60% (EBIT 5.97b / Capital Employed (Equity 14.12b + L.T.Debt 24.14b))
RoIC = 16.02% (NOPAT 5.96b / Invested Capital 37.18b)
WACC = 5.77% (E(59.66b)/V(85.75b) * Re(7.83%) + D(26.09b)/V(85.75b) * Rd(1.06%) * (1-Tc(0.00)))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.70%
[DCF] Terminal Value 86.97% ; FCFF base≈5.50b ; Y1≈5.88b ; Y5≈7.10b
[DCF] Fair Price = 209.3 (EV 210.27b - Net Debt -2.14b = Equity 212.41b / Shares 1.01b; r=5.90% [WACC]; 5y FCF grow 7.63% → 2.90% )
EPS Correlation: 56.22 | EPS CAGR: 8.32% | SUE: 0.12 | # QB: 0
Revenue Correlation: 69.54 | Revenue CAGR: 5.87% | SUE: -2.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.08 | Chg7d=-0.021 | Chg30d=-0.026 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.56 | Chg7d=+0.033 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=+5.1% | Growth Revenue=-0.5%
EPS next Year (2027-12-31): EPS=4.91 | Chg7d=-0.002 | Chg30d=-0.108 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.3% (Discount Rate 7.9% - Earnings Yield 8.2%)
[Growth] Growth Spread = +5.9% (Analyst 5.6% - Implied -0.3%)